Raymond James Upgrades PLx Pharma to Outperform, Announces $14 Price Target
Raymond James analyst Elliot Wilbur upgrades PLx Pharma (NASDAQ:PLXP) from Market Perform to Outperform and announces $14 price target.
70 Biggest Movers From Friday
Gainers
Everspin Technologies, Inc. (NASDAQ: MRAM) shares surged 63.2% to close at $10.74 on Friday after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
PLx Pharma Q3 Adj. EPS $(0.37) Beats $(0.46) Estimate, Sales $6.60M Beat $4.10M Estimate
PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.46) by 19.57 percent. This is a 7.5 percent increase over losses of $(0.40) per share from the same
Earnings Scheduled For November 12, 2021
Companies Reporting Before The Bell
• Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million.
66 Biggest Movers From Friday
Gainers
Bakkt Holdings, Inc. (NASDAQ: BKKT) shares surged 66.1% to close at $42.52 on Friday on continued volatility after the company recently announced partnerships with Mastercard and Fiserv.
PLx Pharma Offers Update On Its VAZALORE Launch: Supplied 3 Stock Keeping Units Of VAZALORE Into 30K+ Retail, Online Stores Successfully
-- Supplied VAZALORE to 30,000+ stores nationwide and e-commerce sites --
-- Launch in line with expectations and exceptionally positive feedback from consumers and healthcare professionals received --
--
44 Biggest Movers From Yesterday
Gainers
Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday.